Jarislowsky, Fraser Ltd’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.59M Sell
141,001
-1,339
-0.9% -$33K 0.02% 112
2025
Q2
$3.45M Sell
142,340
-4,693
-3% -$109K 0.02% 111
2025
Q1
$3.73M Sell
147,033
-11,400
-7% -$298K 0.02% 109
2024
Q4
$4.2M Buy
158,433
+7,209
+5% +$196K 0.02% 106
2024
Q3
$4.38M Sell
151,224
-48,275
-24% -$1.41M 0.02% 108
2024
Q2
$5.58M Sell
199,499
-26,295
-12% -$724K 0.03% 100
2024
Q1
$6.27M Sell
225,794
-25,303
-10% -$702K 0.04% 103
2023
Q4
$7.23M Sell
251,097
-21,905
-8% -$662K 0.04% 98
2023
Q3
$9.06M Sell
273,002
-31,963
-10% -$1.13M 0.06% 89
2023
Q2
$11.2M Sell
304,965
-33,192
-10% -$1.29M 0.07% 86
2023
Q1
$13.8M Sell
338,157
-65,916
-16% -$2.85M 0.09% 84
2022
Q4
$20.7M Sell
404,073
-19,565
-5% -$938K 0.14% 78
2022
Q3
$18.5M Sell
423,638
-58,752
-12% -$2.85M 0.13% 77
2022
Q2
$25.3M Sell
482,390
-21,102
-4% -$1.08M 0.16% 71
2022
Q1
$26.1M Sell
503,492
-22,169
-4% -$1.15M 0.14% 74
2021
Q4
$31M Sell
525,661
-50,365
-9% -$2.5M 0.14% 72
2021
Q3
$24.8M Sell
576,026
-18,090
-3% -$801K 0.12% 73
2021
Q2
$23.3M Sell
594,116
-16,747
-3% -$651K 0.11% 76
2021
Q1
$22.1M Sell
610,863
-47,425
-7% -$1.68M 0.11% 74
2020
Q4
$24.2M Sell
658,288
-55,398
-8% -$2.03M 0.12% 71
2020
Q3
$24.9M Sell
713,686
-40,863
-5% -$1.43M 0.15% 67
2020
Q2
$23.4M Sell
754,549
-27,737
-4% -$942K 0.15% 70
2020
Q1
$24.2M Sell
782,286
-100,520
-11% -$3.43M 0.18% 68
2019
Q4
$32.8M Sell
882,806
-43,446
-5% -$1.55M 0.17% 72
2019
Q3
$31.6M Sell
926,252
-50,231
-5% -$1.83M 0.18% 68
2019
Q2
$40.1M Sell
976,483
-57,914
-6% -$2.3M 0.24% 61
2019
Q1
$41.7M Sell
1,034,397
-100,863
-9% -$4.04M 0.26% 59
2018
Q4
$47M Sell
1,135,260
-16,629
-1% -$690K 0.32% 51
2018
Q3
$47.1M Sell
1,151,889
-290,025
-20% -$11.2M 0.29% 57
2018
Q2
$49.6M Sell
1,441,914
-729,898
-34% -$24.9M 0.3% 58
2018
Q1
$73.1M Sell
2,171,812
-60,130
-3% -$2.07M 0.46% 47
2017
Q4
$76.7M Sell
2,231,942
-6,960
-0.3% -$237K 0.45% 47
2017
Q3
$75.8M Sell
2,238,902
-175,199
-7% -$5.63M 0.45% 49
2017
Q2
$76.9M Sell
2,414,101
-88,260
-4% -$2.78M 0.49% 49
2017
Q1
$81.2M Sell
2,502,361
-500,044
-17% -$15.8M 0.51% 48
2016
Q4
$92.5M Sell
3,002,405
-66,217
-2% -$2.02M 0.59% 41
2016
Q3
$98.6M Sell
3,068,622
-45,812
-1% -$1.53M 0.66% 38
2016
Q2
$104M Sell
3,114,434
-14,463
-0.5% -$462K 0.72% 35
2016
Q1
$88M Sell
3,128,897
-43,909
-1% -$1.25M 0.62% 42
2015
Q4
$97.2M Sell
3,172,806
-26,781
-0.8% -$843K 0.74% 37
2015
Q3
$95.3M Sell
3,199,587
-17,512
-0.5% -$561K 0.72% 40
2015
Q2
$102M Buy
3,217,099
+3,866
+0.1% +$126K 0.7% 39
2015
Q1
$106M Sell
3,213,233
-46,145
-1% -$1.47M 0.71% 36
2014
Q4
$96.3M Sell
3,259,378
-47,111
-1% -$1.35M 0.6% 41
2014
Q3
$92.8M Sell
3,306,489
-39,850
-1% -$1.12M 0.56% 44
2014
Q2
$94.2M Sell
3,346,339
-104,334
-3% -$2.97M 0.53% 44
2014
Q1
$105M Sell
3,450,673
-256,951
-7% -$7.66M 0.61% 39
2013
Q4
$108M Sell
3,707,624
-88,394
-2% -$2.57M 0.61% 41
2013
Q3
$103M Sell
3,796,018
-104,917
-3% -$2.85M 0.61% 39
2013
Q2
$104M Buy
+3,900,935
New +$108M 0.63% 41

Other funds holding PFE

Jarislowsky, Fraser Ltd's PFE Position: Q3 2025 in Review

Jarislowsky, Fraser Ltd reduced its Pfizer (PFE) stake by 0.94% in Q3 2025, selling an estimated $33K and leaving 141,001 shares worth $3.59M. The position accounts for 0.02% of the portfolio, ranked #112.

Jarislowsky, Fraser Ltd first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $108M in Q4 2013. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Jarislowsky, Fraser Ltd held 141,001 shares of Pfizer worth $3.59M as of Q3 2025.
  • Jarislowsky, Fraser Ltd sold 1,339 Pfizer shares in Q3 2025, an estimated $33K.
  • Pfizer made up 0.02% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #112 holding.
  • Jarislowsky, Fraser Ltd first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
  • Jarislowsky, Fraser Ltd's Pfizer position peaked at $108M in Q4 2013.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.